TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32972387

Group type: EXPERIMENTAL
Intervention: Visual impairment
Number of subjects: 2599

Group type: EXPERIMENTAL
Intervention: Visual acuity
Number of subjects: 2599
Study: 35940850

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) for 10 weeks, consisting of 3 days/week of interval training at 60-90% of heart rate reserve
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 32975724

Group type: EXPERIMENTAL
Intervention: Bacillus licheniformis H2 pretreatment
Number of subjects: 180

Group type: COMPARATOR
Intervention: SNE infection group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 180
Study: 32065870

Group type: EXPERIMENTAL
Intervention: Trigone-including BTX-A injection template
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trigone-sparing BTX-A injection template
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both treatment groups (Trigone-including and Trigone-sparing)
Number of subjects: 0
Study: 37947080

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 47
Study: 32955720

Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU weekly) plus magnesium (250 mg daily)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Vitamin D placebo plus magnesium placebo
Number of subjects: 83
Study: 32462950

Group type: EXPERIMENTAL
Intervention: 6-month dietary, exercise, and mindfulness program
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 75
Study: 36107646

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gratitude
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 0
Study: 36379192

Group type: EXPERIMENTAL
Intervention: Cigarettes with varying filter ventilation levels
Number of subjects: 607
Study: 33218310

Group type: EXPERIMENTAL
Intervention: Face-to-face intervention CARE-FAM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online intervention WEP-CARE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of both CARE-FAM and WEP-CARE interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 0
Study: 34340975

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (DEX-) implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatment groups (DEX- implant and bevacizumab)
Number of subjects: 0
Study: 33027082

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 11593409

Group type: EXPERIMENTAL
Intervention: Statin use with diabetes mellitus (DM)
Number of subjects: 11593409

Group type: EXPERIMENTAL
Intervention: Statin use without diabetes mellitus (DM)
Number of subjects: 11593409
Study: 32327447

Group type: EXPERIMENTAL
Intervention: CRISPR-Cas9 system with single-base mismatched sgRNAs
Number of subjects: 0

Group type: COMPARATOR
Intervention: CRISPR-Cas9 system without mismatches
Number of subjects: 0
Study: 32853739

Group type: EXPERIMENTAL
Intervention: Ministernotomy AVR
Number of subjects: 0
Study: 32964296

Group type: EXPERIMENTAL
Intervention: Locked intramedullary nailing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plating
Number of subjects: 50
Study: 32613563

Group type: EXPERIMENTAL
Intervention: Gaseous ozone application during scaling procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group receiving only initial periodontal treatment
Number of subjects: 40
Study: 32771983

Group type: EXPERIMENTAL
Intervention: Gastrointestinal care bundle including individualized dietary counselling weekly and rapid-access investigation and treatment for bowel symptoms.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 50
Study: 33593767

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yellow fever, oral typhoid, and HPV vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV and tetanus/diphtheria booster vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schistosomiasis intervention (trial A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Malaria intervention (trial B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BCG revaccination (trial C)
Number of subjects: 0
Study: 33218522

Group type: EXPERIMENTAL
Intervention: Bowen Therapy (real therapy)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham therapy (control)
Number of subjects: 31
Study: 36384219

Group type: EXPERIMENTAL
Intervention: Shared decision making (SDM) intervention
Number of subjects: 310
Study: 32986891

Group type: EXPERIMENTAL
Intervention: Baclofen (60 mg/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 32325428

Group type: EXPERIMENTAL
Intervention: Ice bag
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Saltwater pack
Number of subjects: 11

Group type: COMPARATOR
Intervention: Chilled surgical steel enswell
Number of subjects: 11

Group type: COMPARATOR
Intervention: Copper
Number of subjects: 11

Group type: COMPARATOR
Intervention: Commercial cold pack
Number of subjects: 11

Group type: COMPARATOR
Intervention: Aluminum
Number of subjects: 11

Group type: COMPARATOR
Intervention: Brass
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ice cube
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ice pack
Number of subjects: 11
Study: 33482793

Group type: EXPERIMENTAL
Intervention: Training ward staff in accordance with falls prevention guidelines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control phase (no intervention)
Number of subjects: 0
Study: 35993151

Group type: EXPERIMENTAL
Intervention: Patient-oriented informative and motivational leaflet
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Participants who stepped down or off PPI
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no leaflet)
Number of subjects: 140
Study: 33906073

Group type: EXPERIMENTAL
Intervention: Policaptil Gel Retard (PGR), 6 tablets/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metformin, 1500–2000 mg/day in two divided doses
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Policaptil Gel Retard (PGR)
Number of subjects: 100
Study: 33687559

Group type: EXPERIMENTAL
Intervention: Maximum effort swallowing
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Minimum effort swallowing
Number of subjects: 43

Group type: COMPARATOR
Intervention: Regular effort swallowing
Number of subjects: 43
Study: 32840955

Group type: EXPERIMENTAL
Intervention: Professionally-based cognitive-behavioral therapy for insomnia (PCBT-I)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Video-based cognitive-behavioral therapy for insomnia (VCBT-I)
Number of subjects: 161
Study: 33504955

Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 39
Study: 32466881

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB) Angioplasty
Number of subjects: 1958

Group type: COMPARATOR
Intervention: Repeat Drug-Eluting Stent (DES) Implantation
Number of subjects: 1958
Study: 36069596

Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion (1 g low‐molecular‐weight iron dextran)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion
Number of subjects: 79
Study: 33792453

Group type: EXPERIMENTAL
Intervention: Zilucoplan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32967685

Group type: EXPERIMENTAL
Intervention: Indacaterol maleate 150 μg once daily (o.d.)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Indacaterol acetate 150 μg once daily (o.d.)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 35108222

Group type: EXPERIMENTAL
Intervention: 10 brushing times
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: 20 brushing times
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: 30 brushing times
Number of subjects: 443
Study: 34994614

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 94
Study: 35359168

Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Dexamethasone 6 mg
Number of subjects: 1000
Study: 33259449

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 58

Group type: COMPARATOR
Intervention: 0.9% NaCl (Control)
Number of subjects: 58
Study: 35190407

Group type: EXPERIMENTAL
Intervention: ivWatch monitoring in addition to standard care
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care (clinical observation)
Number of subjects: 200
Study: 34543725

Group type: EXPERIMENTAL
Intervention: Community-based peer-led sexual and reproductive health services with a loyalty card system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32478922

Group type: EXPERIMENTAL
Intervention: Garlic supplementation (1,000 mg for 8 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 33177439

Group type: EXPERIMENTAL
Intervention: Wall-mounted suction
Number of subjects: 73

Group type: COMPARATOR
Intervention: Handheld syringe suction
Number of subjects: 73
Study: 35903377

Group type: EXPERIMENTAL
Intervention: Fosaprepitant-containing regimen (fosaprepitant, granisetron, and dexamethasone)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Aprepitant-containing regimen (aprepitant, granisetron, and dexamethasone)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Fosaprepitant
Number of subjects: 341
Study: 32763217

Group type: EXPERIMENTAL
Intervention: 25 mg film-coated tablets
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 35 mg film-coated tablets
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 50 mg film-coated tablets or 30 mg dispersible tablets
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 30 mg dispersible tablets or 50 mg film-coated tablets
Number of subjects: 62
Study: 35551331

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study: 32006033

Group type: EXPERIMENTAL
Intervention: Nocturnal eye masks
Number of subjects: 70

Group type: COMPARATOR
Intervention: No eye masks (control)
Number of subjects: 70
Study: 35796669

Group type: EXPERIMENTAL
Intervention: GLP-1
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: GIP
Number of subjects: 32

Group type: COMPARATOR
Intervention: GIP in non-CF controls
Number of subjects: 32
Study: 34414653

Group type: EXPERIMENTAL
Intervention: Traditional Positive Deviance/Hearth (PDH) programme with in-person visits
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: PDH with Interactive Voice Calling (PDH-IVC)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 361
Study: 35963559

Group type: EXPERIMENTAL
Intervention: d‐methylphenidate
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: guanfacine
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: combined treatment
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: combined treatment and guanfacine
Number of subjects: 181

Group type: COMPARATOR
Intervention: clinical measures alone
Number of subjects: 181
Study: 33452967

Group type: EXPERIMENTAL
Intervention: Curcuma longa (1000 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Miconia albicans (1000 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen (1200 mg/day)
Number of subjects: 24
Study: 32798677

Group type: EXPERIMENTAL
Intervention: 3T exFAT trajectories
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: AFQ technique
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Machine Learning classifier analysis
Number of subjects: 120
Study: 616849227

Group type: EXPERIMENTAL
Intervention: Mouldway orthokeratology lenses (M‐OK)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Medcall lenses (ML)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Ordinary frame glasses (OFG)
Number of subjects: 240
Study: 33545575

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0
Study: 35831900

Group type: EXPERIMENTAL
Intervention: PC‐A/C with a 25% reduction in ventilator rate
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CSV (CPAP + PS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Reducing pressure support
Number of subjects: 36

Group type: COMPARATOR
Intervention: CSV mode of ventilation
Number of subjects: 36

Group type: COMPARATOR
Intervention: PC‐A/C mode
Number of subjects: 36
Study: 33630732

Group type: EXPERIMENTAL
Intervention: Non-operative treatment pathway (broad-spectrum antibiotics and active observation)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Appendicectomy
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Qualitative work
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Health economic study
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Core outcome set development
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Survey of surgeons
Number of subjects: 115
Study: 33292009

Group type: EXPERIMENTAL
Intervention: CPAP therapy (initially implemented)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Single-night sleep studies
Number of subjects: 1
Study: 35362819

Group type: EXPERIMENTAL
Intervention: Sharesource® (cloud-based RPM software)
Number of subjects: 15
Study: 32783238

Group type: EXPERIMENTAL
Intervention: High-proanthocyanidin cranberry juice (44 mg proanthocyanidin/240-mL serving) consumed twice daily for 8 weeks
Number of subjects: 522

Group type: COMPARATOR
Intervention: Medium-proanthocyanidin cranberry juice
Number of subjects: 522

Group type: COMPARATOR
Intervention: Low-proanthocyanidin cranberry juice
Number of subjects: 522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522

Group type: COMPARATOR
Intervention: Encapsulated cranberry powder
Number of subjects: 522
Study: 35065664

Group type: EXPERIMENTAL
Intervention: READ-IT programme
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 48
Study: 34890567

Group type: EXPERIMENTAL
Intervention: Intensive high-dose adalimumab plus thiopurine (160 mg adalimumab once per week for 4 weeks followed by 40 mg every 2 weeks, with escalation of dose at 4 months and 8 months if needed; initial dose of azathioprine 2·5 mg/kg or mercaptopurine 1·5 mg/kg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard adalimumab monotherapy (160 mg at week 0, 80 mg at week 2, then 40 mg every 2 weeks)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Intensive high-dose adalimumab plus thiopurine
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard adalimumab monotherapy
Number of subjects: 77
Study: 32966148

Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 0
Study: 35851008

Group type: EXPERIMENTAL
Intervention: Epidural spinal cord stimulation (eSCS)
Number of subjects: 0
Study: 33006007

Group type: EXPERIMENTAL
Intervention: Air Displacement Plethysmography (ADP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dual-Energy X-Ray Absorptiometry (DXA)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Sum of Skinfolds (∑SFT)
Number of subjects: 65
Study: 35179731

Group type: EXPERIMENTAL
Intervention: Early warning system (EWS) using a supervised machine learning algorithm for detection of EAHs.
Number of subjects: 50
Study: 35508304

Group type: EXPERIMENTAL
Intervention: Enhanced LiFE (mobile health device delivered)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adapted LiFE (paper-based)
Number of subjects: 0
Study: 32008420

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 0
Study: 35638317

Group type: EXPERIMENTAL
Intervention: Duloxetine (maximum 60 mg/daily for 18 weeks)
Number of subjects: 25
Study: 33514390

Group type: EXPERIMENTAL
Intervention: Antenatal plasma CMV-DNAemia of > 50 copies/mL
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: HIV-infected mothers with CMV-DNAemia
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: HIV-infected but non-transmitting mothers with CMV-DNAemia of > 50 copies/mL
Number of subjects: 177
Study: 32831069

Group type: EXPERIMENTAL
Intervention: Benznidazole 30d/150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benznidazole 60d/300 mg
Number of subjects: 0
Study: 36107420

Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulation (VR Sim)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Plastic Manikin Simulation (PM Sim)
Number of subjects: 58
Study: 32673939

Group type: EXPERIMENTAL
Intervention: Individualized PEEP ventilation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no PEEP)
Number of subjects: 96
Study: 33092399

Group type: EXPERIMENTAL
Intervention: Reduced fluence CXL (3.8 J/cm2, 7 min)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard CXL (5.4 J/cm2, 10 min)
Number of subjects: 38
Study: 33071159

Group type: EXPERIMENTAL
Intervention: Monitoring weight in SNFs
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Documentation of HF-related signs or symptoms
Number of subjects: 320

Group type: COMPARATOR
Intervention: Health Inspection Star Rating
Number of subjects: 320
Study: 35387819

Group type: EXPERIMENTAL
Intervention: Nelfinavir with chemoradiation and brachytherapy
Number of subjects: 348

Group type: COMPARATOR
Intervention: Chemoradiation and brachytherapy alone
Number of subjects: 348
Study: 34599253

Group type: EXPERIMENTAL
Intervention: N95 respirator
Number of subjects: 44

Group type: COMPARATOR
Intervention: No face covering
Number of subjects: 44
Study: 32551736

Group type: EXPERIMENTAL
Intervention: Virtually delivered Body Project (vBP)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Expressive writing (EW)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 149
Study: 35300651

Group type: EXPERIMENTAL
Intervention: Open Rives sublay technique
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Segregation component technique
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 93
Study: 33623970

Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 0
Study: 32787905

Group type: EXPERIMENTAL
Intervention: TCM formulae (Tiaogan‐BuXu‐Jiedu granules) plus ETV 0.5 mg per day for 96 weeks
Number of subjects: 490

Group type: COMPARATOR
Intervention: TCM granule placebo plus ETV 0.5 mg per day for 96 weeks
Number of subjects: 490
Study: 33397300

Group type: EXPERIMENTAL
Intervention: Multimedia DVD education
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Text messaging education
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (conventional pamphlets)
Number of subjects: 120
Study: 32422244

Group type: EXPERIMENTAL
Intervention: Self-regulated online training with hands-on training supported by peers
Number of subjects: 808

Group type: COMPARATOR
Intervention: Face-to-face education by trained educators
Number of subjects: 808
Study: 34784719

Group type: EXPERIMENTAL
Intervention: Functional broth (CF) enriched with 5.6 g FOS/100 g
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control broth (CC) with 0.4 g maltodextrin/100 g
Number of subjects: 18
Study: 32825994

Group type: EXPERIMENTAL
Intervention: Saddle Hippotherapy Group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Blanket Hippotherapy Group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 30
Study: 37291264

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (20 min, 2 mA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 18
Study: 33608485

Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HI)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Low-to-Moderate Intensity Exercise (LMI)
Number of subjects: 394
Study: 32817358

Group type: EXPERIMENTAL
Intervention: Lacosamide (up to 12 mg/kg/day or 400 mg/day)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 35633927

Group type: EXPERIMENTAL
Intervention: PRECEDE management intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (125 doctors)
Number of subjects: 112
Study: 32331820

Group type: EXPERIMENTAL
Intervention: Surgery (lobectomy, pneumonectomy, sublobar resection)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both modalities (surgery and radiotherapy)
Number of subjects: 88
Study: 32348303

Group type: EXPERIMENTAL
Intervention: Qualitative data collection through in-depth interviews, participant observation, and photovoice over 18 months.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Social norms and reproductive agency (distributed agency) influencing decision-making.
Number of subjects: 15
Study: 36170448

Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 34161883

Group type: EXPERIMENTAL
Intervention: Endocrine therapy (ET) with letrozole+ribociclib
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 194
Study: 33569865

Group type: EXPERIMENTAL
Intervention: MLV‐RAL 0.05%/0.1% cream
Number of subjects: 23

Group type: COMPARATOR
Intervention: Retinol 0.05%/0.1% cream
Number of subjects: 23
Study: 34980827

Group type: EXPERIMENTAL
Intervention: Topical application of an oxygen-enriched oil-based gel, applied 3 times daily for 10 days
Number of subjects: 30
Study: 34187387

Group type: EXPERIMENTAL
Intervention: Usual care plus active cycling in bed
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 51
Study: 32101996

Group type: EXPERIMENTAL
Intervention: Induction therapy (IT)
Number of subjects: 4388

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (IT)
Number of subjects: 4388
Study: 36106379

Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel (≤8mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33126867

Group type: EXPERIMENTAL
Intervention: HA-SIB-WBRT (Hippocampal Avoidance with Simultaneous Integrated Boost Whole Brain Radiotherapy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: HA-WBRT (Hippocampal Avoidance Whole Brain Radiotherapy)
Number of subjects: 100